ALEXANDRIA, Va., May 19 -- United States Patent no. 12,629,350, issued on May 19, was assigned to KANEKA Corp. (Osaka, Japan), EDUCATIONAL FOUNDATION KYUSHU BUNKA GAKUEN (Sasebo, Japan) and NATIONAL UNIVERSITY CORPORATION KUMAMOTO UNIVERSITY (Kumamoto, Japan).

"Transthyretin tetramer stabilizing agent, and preventing agent or progression suppressing agent for transthyretin amyloidosis" was invented by Jinko Sawashita (Osaka, Japan), Yukio Ando (Sasebo, Japan), Hiroaki Matsushita (Sasebo, Japan), Mitsuharu Ueda (Kumamoto, Japan), Teruaki Masuda (Kumamoto, Japan) and Yohei Misumi (Kumamoto, Japan).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are a transthyretin tetramer stabilizing agent and a preven...